skip to main content

Thiazide Hyponatraemia — ESENeph MCQ

Instant feedback + full explanation. One question, done properly.

HardElectrolyte DisordersThiazide HyponatraemiaESENeph

A patient taking indapamide 2.5 mg for hypertension is euvolaemic but develops sodium 126 mmol/L after treatment initiation. Thyroid and adrenal tests are normal. What is the most likely drug-related diagnosis?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DThiazide-like diuretic-associated hypotonic hyponatraemia

The best answer is “Thiazide-like diuretic-associated hypotonic hyponatraemia”. Indapamide is a thiazide-related diuretic that can cause clinically important hyponatraemia, sometimes initially asymptomatic. Plasma sodium should be measured before treatment and at regular intervals, and the medicine and other contributors are reviewed when hyponatraemia occurs. “Pseudohyponatraemia caused by indapamide-induced hyperlipidaemia” is less appropriate because indapamide directly causes true water-electrolyte disturbance rather than this laboratory artefact “Hypernatraemia from excessive distal sodium reabsorption” is less appropriate because the measured abnormality and recognised diuretic effect are in the opposite direction “Primary hyperaldosteronism induced by indapamide” is less appropriate because the medicine does not cause an autonomous adrenal disorder and this would not explain the sodium pattern “Acute glomerulonephritis caused by indapamide” is less appropriate because there is no nephritic urine or kidney-function pattern to support glomerulonephritis

Reference: Indapamide 2.5 mg Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/14345/smpc